News FocusScience and the Stimulus

Science and the Stimulus

+ See all authors and affiliations

Science  27 Nov 2009:
Vol. 326, Issue 5957, pp. 1176-1177
DOI: 10.1126/science.326.5957.1176

You are currently viewing the summary.

View Full Text

Summary

The huge research windfall from the Recovery Act—the National Institutes of Health (NIH) was given $10.4 billion, the National Science Foundation (NSF) $3 billion, and the Department of Energy (DOE) received $2 billion for basic research—presented these agencies with a unique opportunity to catch up from previous shortfalls. But it also put pressure on them to find ways to avoid a disruptive boom-and-bust cycle. In a special package of stories this week, Science examines what NIH (see p. 1179), NSF (see p. 1181), and DOE (see p. 1177) did with that flexibility and how their choices will leave a deep imprint on U.S. research for years to come. The final story in the package examines a controversial area of research jump-started with $1.1 billion in stimulus money: comparative evaluation of medical treatments (p. 1183).